Dyslipidemia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Dyslipidemia is a lipoprotein metabolism disorder characterized by abnormal amount of lipoprotein (LDL and HDL) concentrations in blood. It is usually caused by genetic factors, secondary factors or a combination of both kinds of factors. High density lipoproteins (HDL) are also known as good cholesterol and higher levels of these help reduce the risk of cardiovascular diseases. Higher levels of low density lipoproteins (LDL) or bad cholesterol are associated with the risk of heart attacks and strokes. 

Browse full report at: http://www.transparencymarketresearch.com/dyslipidemia-market.html

The abnormal levels of cholesterol and triglycerides are capable of producing three forms of dyslipidemia namely, hypertriglyceridemia, hypercholesterolemia and a combination of both. Dyslipidemia is one of the major causes for the occurrence of cardiovascular diseases. Appropriate drug therapy against dyslipidemia can be selected based on the detection of varying concentrations of specific lipoproteins in the blood. The treatment approach adopted by physicians starts with non-drug interventions, which includes lifestyle modifications and exercise followed by pharmacotherapy which includes the use of lipid lowering drugs. 

The seven major classes of lipid lowering drugs used in the treatment of dyslipidemia are bile-acid sequestrants, nicotinic acid, HMG-CoA reductase inhibitors (statins), cholesterol modulators, fibric acid derivatives, cholesterol absorption inhibitors and combination products. Statins are the most widely used drugs to treat dyslipidemia. The dyslipidemia market can be segmented by the various drug classes mentioned above and by geography.  

The major factors influencing the growth of this market are sedentary lifestyle, higher inclination towards junk food, increasing incidence of cardiovascular diseases across the globe and associated risks. Patent expirations and high genericization may mask the growth of this market. With the patent expiration of Pfizer’s Lipitor, Merck’s Zocor and Bristol-Myers Squibb’s Pravachol, the dyslipidemia market is expected to experience a decline in sales of branded formulations and in turn decline in overall growth of this market. Some of the major players in this market are Pfizer, Inc., Merck & Co, Inc., Bristol-Myers Squibb, Novartis AG, AstraZeneca PLC and Abbott Laboratories. 

More reports on Pharmaceuticals market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Bioterrorism Detection Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Bioterrorism refers to form of terrorism that involves intentional dissemination or release of biological agents. The agents can be viruses, bacteria or toxins and can also be referred to as germ warfare. Biological agents are mainly found in nature but sometimes they can be modified by the terrorist as to make agents more toxic. Biological agents are used by the terrorists to attain their social or political goals and are used for killing or injuring people, plants and animals. Biological weapons are dangerous as some of these agents are transmitted from one person to another and infection might take hours or days to become noticeable.

Browse full report at: http://www.transparencymarketresearch.com/bioterrorism-detection-market.html

Bioterrorism is an invaluable tool as biological agents are relatively inexpensive and can cause widespread fear beyond the actual damage they can cause. They are mainly used by the terrorists to create mass panic and disruption of state or economy. The global market for bioterrorism is segmented on the type of different biological agents currently being used and their mode of delivery.  Agents such as anthrax, tularemia, small pox, bubonic plague, botulinum toxin and viral hemorrhagic fevers pose a high threat to national security. 

Another category involves toxins such as typhus, glanders, Q fever, viral encephalitis and others poses moderate threat and involves low mortality. Last category involves emerging toxins that are engineered for mass dissemination, high mortality rate and ability to cause major health impact. Hantavirus, Nipah Virus, SARS, HIV/AIDS and H1N1 virus falls under this above mentioned category. The mode of delivery of these biological agents can be via aerosol dissemination, water contamination, food contamination, insect vectors and others.

However, federal government supports many programs and researches but it does not provide any direct protection against bioterrorists attacks for many important buildings. These buildings include theaters, shopping centers, large buildings and others. In the United States virtually all these buildings remain susceptible to bioterrorist attack. Key protection to these facilities involves the presence of warning systems which provide immediate response to such attacks.

Some of the major players that provide and bioterrorism defense products are Acambis Plc, Evogen, Inc., Human Genome Sciences, ICX Technologies, Inc., PharmAthene, Inc. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceuticals market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Global Blood Disease Treatment Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Blood comprises of red blood cells, white blood cells, plasma and platelets. Sometimes, people might be affected with different types of blood disorders and blood cancers due to aging, infections, exposure to certain chemicals, smoking, genetic disorders and other factors. Hence, the category of blood disorders is wide and numerous types of diseases fall under it. 

Browse full report at: http://www.transparencymarketresearch.com/blood-disease-treatment-drugs.html

There are three main types of cancer that affect blood namely leukemia which affects the bone marrow and is caused by abnormal production of white blood cells. Myeloma is a type of blood cancer that affects plasma cells whereas lymphoma is a cancer that affects the lymphatic system. The diseases that affect white blood cells are mainly lymphoma and leukemia and  anemia, sickle cell anemia and polycythemia diseases are mainly affecting red blood cells. Diseases such as heparin, thrombocytopenia and essential thrombocytosis affect the platelets found in blood and hemophilia and sepsis affect blood plasma. 

Hematological cancers represent a significant problem globally. Every year more than 100,000 cases of blood cancers are diagnosed in United States and more than 50,000 people die from such cancer cases. Many specific therapies for the treatment of cancers have been developed that include biologics and small-molecule drug therapies. Leukemia accounts for the ninth most common occurring cancer in males across the globe. Leukemia market is segmented into four types that include acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Thus, with the rise in number of cancer cases the market in future is projected to grow. 

Drugs such as Sprycel, Arranon, Clolar, Gleevec, Quizartinib, Marqibo, and Tasigna are the major drugs available for the treatment of leukemia. The blood diseases treatment drugs market is witnessing competition among the players with drugs in pipeline for early diagnosis and treatment of blood disorders.  

Some of the key players in the blood disease treatment drugs market include Novartis International AG, Celgene Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals, Ambit Bioscience and other major players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceutical market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This brings a market of about 7.5 million people suffering from combined disorders of schizophrenia, bipolar disorder, dementia, depression among other rare conditions. 

Browse full report at: http://www.transparencymarketresearch.com/antipsychotic-drugs-market.html

Several recent studies have suggested instances of drug abuse and over prescription of these drugs in the market, particularly in North America. Clinical studies have shown severe drawbacks and addiction to antipsychotic drugs. A serious side effect observed is tardive dyskinesia which is a potentially irreversible movement disorder. These drugs are prescribed for mild symptoms as well, increasing the market for the drugs tremendously.

Antipsychotics market is expected to increase with increasing incidences of Schizophrenia and a very large market of clinical depression. Certain drugs such as Ablify and Seroquel are the topmost in the segment due to their advantage of reduced risk of side-effects. 2012 has observed the end of the several drug patents and it is expected that generic drugs will compete strongly in the market in the coming years. There is an increasing general call in the medical community for adoption of a stronger control while administering these drugs in the coming years. 

Aripiprazole (marketed as Abilify), Asenapine Maleate (marketed as Saphris), Clozapine (marketed as Clozaril), Iloperidone (marketed as Fanapt), Lurasidone (marketed as Latuda), Olanzapine (marketed as Zyprexa), Olanzapine/Fluoxetine (marketed as Symbyax), Paliperidone (marketed as Invega), Quetiapine (marketed as Seroquel), Risperidone (marketed as Risperdal) and Ziprasidone (marketed as Geodon) are the major atypical antipsychotic drugs marketed today. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceuticals market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Uranium Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Uranium is mostly used in nuclear power plants to generate electricity. The rising demand for electricity and the capacity of nuclear reactors is driving the uranium market. The global uranium market is expected to witness significant growth in next six years. Nearly 75% of uranium supply is through mining activity and it is expected to grow further in the coming years. 

Browse full report at: http://www.transparencymarketresearch.com/uranium-market.html

Other secondary sources of uranium include civil stockpiles, recycled uranium, and ex-military weapons-grade uranium. It is expected that there will be a balance between the demand and the supply as the number of new reactors being constructed and old plants retiring is nearly the same. 

In the next six years, it is expected that China, Russia, India, the Middle East, and Europe will expand their use of nuclear energy, creating intense competition for mined uranium. China and Russia are the fastest growing markets and they have already started buying huge stakes in uranium mining operations. 

In 2011, after the incident of Fukushima Daiichi reactor owing to Japan’s tsunami and earthquake, the uranium market might witness slow growth. Shortage of uranium may be experienced in the next few years in spite of the abundance of uranium in the earth’s crust, but it takes many years to build and finance uranium mining operations. 

Some of the major factors driving the market are the growing demand for nuclear energy, the economic advantage associated with uranium production, oil price fluctuations, and increased awareness regarding reducing carbon emissions. The restraint faced by the industry is the high entry barrier because it is a highly capital intensive industry and requires a long time to obtain mining permits. Owing to environmental concerns, obtaining a uranium mining permit is a major challenge.  

The global uranium industry is highly concentrated as very few players are operating in relatively few countries. Russia’s Rosatom and Kazakhstan’s Kazatomprom have entered into a joint venture to dominate the uranium market. Some of the key participants in the market are Cameco Corp., African Energy Resources Ltd, Energy Resources of Australia Ltd, American Uranium Corp. Inc., National Atomic Company Kazatomprom, China National Nuclear Corp., Gulf Mines Ltd., and JOGMEC. 

More reports on Pharmaceutical market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Browse another blog: http://marketingresearchfirm.wordpress.com

Read More

Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can affect any part of the body. Symptoms include imbalance, loss of motor function, spasms, numbness, incontinence, and difficulty in swallowing. 

Browse full report at: http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html

There is no known cure for the disease currently and the only drugs available in the market are for delaying the progression of the disease. MS is estimated to affect 2.5 million people worldwide with around 5000 new cases developing each year. The National Multiple Sclerosis Society, Multiple Sclerosis Foundation, Multiple Sclerosis Association of America and several others are organizations which are determined to ensure improvement in the lives of affected people to make them more educated and spread awareness of this disease.

Until the last year, the MS drugs market was led primarily by injectables, yet this trend is changing very quickly to give way to oral MS drugs which is expected to grow strongly beginning from 2013. Gilenya and Aubagio are the top current oral drugs in this segment and Biogen’s oral BG-12 and Teva Laquinimod are two other drugs in the pipeline for approval with a significantly higher efficacy to be launched in the next five years. Although oral MS drugs seem to be growing quickly, it is not expected that they would unsettle injectables anytime soon. 

Several fatal side effects have been linked to use of Gilenya among those who have a heart disease and thus shows that there is still a long way to go for oral MS drugs. Top contenders in this segment till now are Copaxone, Avonex, Rebif, Betaseron, and Tysabri. Most of these drugs work actively to control MS relapses. Other treatments such as stem-cell transplantation are currently under investigation. The process includes the injection of stem cells which will replace the affected inflamed and diseased cells, greatly improving patient’s quality of life.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceutical market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Micro-RNA Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Micro-RNA is a small non-coding RNA molecule which is a vital component of genetic regulation. Set of micro-RNAs are present in plants and animals functioning in gene expression process. They are involved in the normal functioning of the eukaryotic cells. Biogenesis of micro-RNA is the basis for RNA interference drug discovery and research in therapeutics. 

Browse full report at: http://www.transparencymarketresearch.com/micro-rna-market.html

Micro-RNAs are likely to be involved in biological processes by affecting the gene regulation. Research and development of micro-RNA based therapies are recently being exploited due to the implication of unusually expressed micro-RNA in numerous disorders such as cancer, cardiovascular diseases and HIV infections.

The global micro-RNA market if categorized into:

1. Applications

• Research
• Diagnosis
• Therapeutics

2. Technology

• Purification
• Labeling
• Linear amplification
• Microarrays
• qRT-PCR
• Inhibition

Globally, North America and Europe are the leading regions with booming micro-RNA market. Emerging economies of Asia such as India, Japan, China and Singapore as well as the Middle East and Latin American countries are also expected to show soaring progress in the growth of micro-RNA market.

One of the key factors driving the global micro-RNA market is provision of large scale funding by public and private sectors. Other factors responsible for the growth of this market are growing interest of pharmaceutical and biotechnological companies in conducting research on micro-RNAs and identification of micro-RNA role in different disease classes.

Some of the major players contributing to the global micro-RNA market comprises Access Pharmaceuticals, Agilent Technologies, Astrazeneca Pharmaceuticals LP, Benitec Biopharma Limited, Calando Pharmaceuticals, Inc., Covance, Inc., Eli Lilly and Co., F. Hoffman-La Roche AG, Illumina, Inc., Novartis International AG, Senesco Technologies, Inc., Sirnaomics, Inc., Tekmira Pharmaceuticals Corporation and Thermo Fisher Scientific, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceutical market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More